As a member of the Janssen Pharmaceutical Companies, Janssen, a division of Johnson & Johnson Limited is dedicated to addressing and solving the unmet medical needs in Primary Care and Specialty Care (Central Nervous System, Oncology, Nephrology, Dermatology and Immunology)
Our ultimate goal is to help people live healthy lives. We have produced and marketed many first-in-class prescription medications and are poised to serve the broad needs of the healthcare market – from patients to practitioners, from clinics to hospitals.
Janssen is proud to offer a wide range of prescription pharmaceuticals in several therapeutic areas, to treat both widespread and rare conditions, both isolated and common medical needs. Driven by our commitment to the passionate pursuit of science for the benefit of patients, we work to bring innovative products and services in the areas of Nephrology (Eprex®), Pain (Ultracet®, Osteosolve®), Gastro (Stugeron®, Kyrab, Kyrab-D®, Stugil®), Derma (Nizral®, Retino-A®, Triatop®, Sporanox®), CNS (Topamac™, Risperdal®, Risperdal Consta®, Sibelium®, Prelogic™), Oncology (Durogesic™, Velcade®, Yondelis®, Dacogen™, Caelyx®) and Immunology (Remicade®).
Pursuing the commitment to addressing serious unmet medical needs, Janssen is dedicated to supporting healthcare professionals, patients, and caregivers with support programs and services that reflect high standards of business conduct and Our Credo values.